Mometasone Furoate Ointment
Product Images NDC 45802-119

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mometasone Furoate (NDC 45802-119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure diagram of mometasone furoate, showing its molecular arrangement including rings, functional groups, and atoms such as chlorine and oxygen.*

FDA Label Image

Image 02

Packaging label for Mometasone Furoate Ointment USP 0.1%, topical ointment, 15 g tube. The label states it is for dermatologic use only and not for ophthalmic use. Manufactured by Padagis Israel Pharmaceuticals Ltd and distributed by Perrigo. Includes storage instructions and barcodes. Marked Rx Only.*

FDA Label Image

Serialization Template

A blank product label area for Mometasone Furoate ointment 1 mg/g by Padagis Israel Pharmaceuticals Ltd, designed to display the serial number (S/N), lot number, and expiration date. The label includes placeholders bracketed with instructions to insert the product’s serial number, lot number, and expiration date for identification and tracking.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.